Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF - Get Free Report)'s share price hit a new 52-week low during mid-day trading on Friday . The company traded as low as $22.36 and last traded at $22.36, with a volume of 765 shares changing hands. The stock had previously closed at $22.91.
Hikma Pharmaceuticals Trading Down 0.7%
The business's 50 day moving average price is $25.47 and its 200-day moving average price is $26.44. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.24 and a quick ratio of 0.72.
About Hikma Pharmaceuticals
(
Get Free Report)
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
Read More
Before you consider Hikma Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hikma Pharmaceuticals wasn't on the list.
While Hikma Pharmaceuticals currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
